Abstract:Introduction: The clinical use of the antitumoral drug doxorubicin (Dox) is reduced by its dose-limiting toxicity, related to cardiotoxic side effects and myelosuppression. In order to overcome these drawbacks, here we describe the synthesis, the structural characterization and the in vitro cytotoxicity assays of hydrogels (HGs) and nanogels (NGs) based on short peptide sequences loaded with Dox or with its liposomal formulation, Doxil. Methods: Fmoc-FF alone or in combination with (FY)3 or PEG8-(FY)3 peptides, at two different ratios (1/1 and 2/1 v/v), were used for HGs and NGs formulations. HGs were prepared according to the "solvent-switch" method, whereas NGs were obtained through HG submicronition by the top-down methodology in presence of TWEEN®60 and SPAN®60 as stabilizing agents. HGs gelation kinetics were assessed by Circular Dichroism (CD). Stability and size of NGs were studied using Dynamic Light Scattering (DLS) measurements. Cell viability of empty and filled Dox HGs and NGs was evaluated on MDA-MB-231 breast cancer cells. Moreover, cell internalization of the drug was evaluated using immunofluorescence assays. Results: Dox filled hydrogels exhibit a high drug loading content (DLC=0.440), without syneresis after 10 days. Gelation kinetics (20-40 min) and the drug release (16-28%) over time of HGs were found dependent on relative peptide composition. Dox filled NGs exhibit a DLC of 0.137 and a low drug release (20-40%) after 72 h. Empty HGs and NGs show a high cell viability (>95%), whereas Dox loaded ones significantly reduce cell viability after 24 h (49-57%) and 72 h (7-25%) of incubation, respectively. Immunofluorescence assays evidenced a different cell localization for Dox delivered through HGs and NGs with respect to the free drug. Discussion: A modulation of the Dox release can be obtained by changing the ratios of the peptide components. The different cellular localization of the drug loaded into HGs and NGs suggests an alternative internalization mechanism. The high DLC, the low drug release and preliminary in vitro results suggest a potential employment of peptide-based HGs and NGs as drug delivery tools.

An Injectable Drug-Loaded Hydrogel Based on a Supramolecular Polymeric Prodrug.

Injectable doxorubicin-loaded hydrogels based on dendron-like beta-cyclodextrin-poly(ethylene glycol) conjugates

Peptide-Based Hydrogels and Nanogels for Delivery of Doxorubicin

An injectable and biodegradable hydrogel based on poly(α,β-aspartic acid) derivatives for localized drug delivery

In Situ Gelation of Supramolecular Hydrogel for Anti-Tumor Drug Delivery.

Injectable poly(ethylene glycol) hydrogels for sustained doxorubicin release

An Injectable Thermo-Responsive Hydrogel Based Cellulose-Brush Derivative for the Sustained Release of Doxorubicin

Zwitterionic Supramolecular Prodrug Nanoparticles Based on Host-Guest Interactions for Intracellular Drug Delivery

Versatile Injectable Supramolecular Hydrogels Containing Drug Loaded Micelles for Delivery of Various Drugs

Injectable small molecule hydrogel as a potential nanocarrier for localized and sustained in vivo delivery of doxorubicin

Ph Triggered Injectable Amphiphilic Hydrogel Containing Doxorubicin and Paclitaxel

Biocompatible supramolecular hydrogels based on polysaccharide-modified hyaluronic acid for targeted delivering of doxorubicin

The Supramolecular Hydrogel Based on Hyperbranched Polyglycerol and Dextran As A Scaffold for Living Cells and Drug Delivery

Supramolecular Hydrogels As a Universal Scaffold for Stepwise Delivering Dox and Dox/cisplatin Loaded Block Copolymer Micelles

Synthesis and Application of Injectable Bioorthogonal Dendrimer Hydrogels for Local Drug Delivery.

Schiff base-containing dextran nanogel as pH-sensitive drug delivery system of doxorubicin: Synthesis and characterization

Injectable Supramolecular Hydrogels Based on Host–guest Interactions with Cell Encapsulation Capabilities

A Facile Strategy For In Situ Controlled Delivery Of Doxorubicin With A Ph-Sensitive Injectable Hydrogel

Short and simple peptide-based pH-sensitive hydrogel for antitumor drug delivery

An injectable drug-loaded hydrogel using a “clickable” amphiphilic triblock copolymer as a precursor

Nanospheres of doxorubicin as cross-linkers for a supramolecular hydrogelation